Albuquerque’s InLight Solutions, makers of biometric and life sciences measurement and identification equipment, has received a $250,000 federal grant to support the company’s non-invasive diabetes screening technology. New non-invasive Instrument to screen for diabetes: The Scout
Measures advanced glycation end products (AGEs) in the dermis of the forearm.
Albuquerque’s InLight Solutions, makers of biometric and life sciences measurement and identification equipment, has received a $250,000 federal grant to support the company’s non-invasive diabetes screening technology.
InLight Solutions has developed the Scout instrument to revolutionize screening for Type 2 diabetes. Scout employs fluorescence spectroscopy to noninvasively measure advanced glycation endproducts (AGEs) in the dermis of a subject’s forearm. The concentration of AGEs in the dermis is an excellent indicator of cumulative hyperglycemic exposure and is highly correlated with the development of diabetes complications8.
The accurate and reproducible (5% inter-day coefficient of variation) Scout measurement can be made anytime of day because fasting is not required. There are no needles or biohazards. The Scout test is simpler to do than a blood pressure test and takes less than 60 seconds to produce a quantitative result. The physician can immediately interpret the Scout results to determine if further diagnostic work-up is warranted. The Scout test eliminates the hassle of a separate trip to the reference laboratory. In addition, it reduces patient compliance and test result reporting issues. Scout’s performance and convenience enable widespread, opportunistic diabetes screening of the at risk patient population.